Obstacles and Policy Measures Toward COVID-19 Vaccination: Creating a Sustainable Road Map for Malawi |
| |
Authors: | Oladapo Rasaq Kayode Onyinyechi Patience Obidiro Usen Stephanie Lawrence Afeez Babatunde Oyetola Mohammad Mehedi Hasan Adekunle Olajide Olajide Mariam Olaitan Zarmina Islam Abdulhafeez Ayodele Mustapha Eze Osuagwu-Nwogu Shamas Ghazanfar Olaleye Modinat Aderonke |
| |
Affiliation: | 1. Nigerian Red Cross Society (NRCS), Lagos, Nigeria;2. Pharmacists Council of Nigeria, Lagos, Nigeria;3. Howard University Global Initiative, Nigeria (HUGIN), Calabar, Nigeria;4. Department of Biochemistry and Molecular Biology, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Tangail 1902, Bangladesh;5. School of Pharmacy, Chapman University, Irvine, CA, USA;6. Department of Urban and Regional Planning, Obafemi Awolowo University, Ile Ife, Osun State, Nigeria;7. Dow University of Health Sciences, Karachi, Pakistan;8. Faculty of Pharmacy, Obafemi Awolowo University, Ile Ife, Osun State, Nigeria;9. Heartland Alliance Nigeria, Lagos, Nigeria;10. Dow Medical College, Karachi, Pakistan |
| |
Abstract: | ![]() The Coronavirus Disease 2019 (COVID-19) pandemic is a public health threat for Malawi which is facing several challenges concurrently including disease burden; inadequate finances; illiteracy; and public mistrust in government. In this pandemic, vaccines are the most reliable and cost-effective public health intervention, and the Malawian government has instituted an action plan which includes prioritizing the vaccination of traditional and religious leaders, increased vaccination sites to include workplaces and shopping malls, and health promotion. However, there is still considerable hesitancy around the use of the available vaccines in Malawi. In this paper, we explore the multiple interrelated factors driving COVID-19 vaccine hesitancy in Malawi. It is therefore recommended that the Malawian government embrace multicomponent and wide-ranging strategies to address COVID-19 vaccine hesitancy in the country. This includes reviving trust in national health authorities by offering population-specific, target-driven, and effective, transparent, and timely communication to its citizens and relevant stakeholders about the safety and efficacy of the COVID-19 vaccine. |
| |
Keywords: | Pandemic COVID-19 COVID-19 vaccine Vaccine Hesitancy Communication |
本文献已被 ScienceDirect 等数据库收录! |
|